Evan Shlofmitz

Intense, yet fabulous, hands-on pre-course imaging session just concluded! Key points: Not all calcium is the same Expansion is more critical than apposition It’s okay to look at CCTA even if you’re interventional Just do IVI

Today we completed the first cases using the HyperVue Integrated System at @StFrancis_LI , performed by Dr. Richard A. Shlofmitz and @DrAllenJ. This milestone marks the first platform directly installed into the cath lab that combines DeepOCT+NIRS and X1-FFR physiology in one system — delivering efficient workflows and precise insights for PCI optimization. Thank you to the team at St. Francis for partnering with us on this big step forward in interventional cardiology!

Watch Now | OPCI Journal Club: Impact of Pullback Pressure Gradient on Clinical Outcomes after PCI presented by @ColletCarlos. With panelists @djc795 @ESHLOF @DrAllenJ @JWMoses. opci.live/journal-club/

Wireless angiography-derived physiology (ADP) has the potential to address key limitations of invasive wire-based assessment by streamlining workflow and reducing costs and procedural time. In a SCAI roundtable, four experts discuss the advantages and limitations of ADP. Watch the roundtable discussion ➡️ youtu.be/lBlEdrSghxc?si… #InterventionalCardiology #CardioX @ESHLOF @wfearonmd @djkereiakes @B_Krogsgaard @myjscai

Watch Now | OPCI Journal Club: "Procedural and Clinical Outcomes After Orbital Atherectomy Versus Intravascular Lithotripsy in Patients with Calcified Nodules." Presented by @DoosupShin along with panelists @djc795 @DrAllenJ @JWMoses @ESHLOF. opci.live/journal-club/

JOIN US TONIGHT! For the #Spring #2026 Long Island Fellows Forum! Space is limited so RSVP!

Paciente del @VulnerableTrial con dos placas vulnerables elegibles para el estudio. Ojala hubieramos tenido Ultreon 3.0 desde el principio del estudio. Excelente deteccion automatica de lipido (azul).

#ctguidedpci is here. Standing room only at the @scai #scai2026 lunchtime session. Rewarding to work with interventional colleagues on this new pathway. @eshlof ⁦@ziadalinyc⁩ ⁦@Heart_SCCT⁩ @faroucjaffer

@s7saith @CathWhisperer @SCAI @SrihariNaiduMD @sahilparikhmd @Pooh_Velagapudi @ladyheart_md @SultanaJahanMD @Shikha_Cardio @OBHCardiology @sunydownstate Saturday @2 pm @SCAI we’ll be discussing just that. Looking fwd to the discussions.

Less than 48 hrs after #ACC2026, I gave a lecture on IVUS/OCT to @OBHCardiology & @sunydownstate Fellows. With the smoke clearing, I am most looking forward to the discussions @SCAI #scai2026 about what the data from these trials are actually saying...and how they compare to prior metas. Defining- and defending the role of intracoronary imaging to current #ACCFIT is crucial @ESHLOF @ziadalinyc

Before Day 1 of #SCAI2026 begins tomorrow, here are the key sessions & questions I’ll be watching most closely. What might actually change how we think 🧵 @SCAI @SrihariNaiduMD @sahilparikhmd @Pooh_Velagapudi @ladyheart_md @s7saith @SultanaJahanMD @Shikha_Cardio

@SCAI think tanks during #SCAI2026 partner with industry stakeholders expert interventionalists on key field-wide issues in interventional cardiology. Leading into clinical practical guidance and other tangible deliverables. Run this year by @Babar_Basir @agtruesdell @ESHLOF

Bringing CT-Guided PCI into the cath lab! First CT-Guided PCI case using PCI Navigator in the NAVIGATE-PCI study. Looking forward to the insights this study will provide and the changes in practice this technology will lead to. Incredible seeing how PCI navigator showed us everything OCT did for pre-procedural planning. #NAVIGATEPCI #HeartFlow @OptimizingPCI @StFrancis_LI @CHS_LI @Heartflow @rooshaparikh @ziadalinyc @JWMoses @DrAllenJ @DoosupShin @FernanOCT @PaulSap9 @OKhaliqueMD @djc795 @heartsmartpro

St. Francis is the first in the tristate region to perform a TMVR (transcatheter mitral valve replacement) using the Edwards M3 device, recently approved by the FDA.  This procedure is for patients who are high risk for open heart surgery with severe mitral valve disease.

And we’re off! First HeartFlow NAVIGATE-PCI case. Precision in PCI isn’t just by IVUS/OCT anymore— the standard has expanded to CT-Guided PCI. NAVIGATE-PCI will test how data-driven tools can optimize decision-making, streamline workflow, and improve outcomes in the cath lab. Optimal PCI is guided, precise, data-driven inside #ctguidedpci or outside #imagefirst the lab @Heartflow @StFrancis_LI @ESHLOF @DrAllenJ @djc795 @DoosupShin @rooshaparikh @OKhaliqueMD @CathElectroSurg @JWMoses @ColletCarlos @yadersandoval @manosbrilakis @kalazizimd

Journal Club: Intravascular imaging vs angiography guided complex PCI The RENOVATE-COMPLEX-PCI 5-year outcomes confirm the long-term durability of benefits seen with intracoronary imaging over angiography guided PCI in complex lesions. Selected in @JACCJournals & reviewed ✍️ by @McInerneyAngela #interventionalcardiology #imagefirst

My thoughts on angio-based FFR are summarized in this NEJM editorial. Both FAST III and ALL-RISE - nearly identical in design and results - send a clear message that angio-based FFR is easy, safe, fast, and efficacious. Practice changing! nejm.org/doi/pdf/10.105…

#ACC26 #ALLRISE 🛠️ Intervention comparison: FFRangio (angiography-derived physiology) vs traditional pressure-wire–based FFR/NHPR 🧠 Primary hypothesis: FFRangio-guided strategy is non-inferior to pressure-wire guidance for 1-year MACE ✅ Primary endpoint met (non-inferiority) — MACE 6.9% vs 7.1%, HR 0.98 (P<0.001 NI) ⚖️ Hard outcomes equivalent — death, MI, and revascularization all similar → no safety trade-off ⚡ Procedural efficiency advantage — shorter time, less fluoroscopy, less contrast (workflow benefit) ⚠️ Signal of increased PCI rates — more lesions treated (44% vs 35%) ? over-treatment bias 🧠 Interpretation — simplified physiology without loss of outcomes comparable to CT FFR? #yesCCT

Presented at #ACC26: Among patients with atherosclerotic cardiovascular disease, targeting an LDL cholesterol level below 55 mg per deciliter led to a lower 3-year risk of cardiovascular events than targeting a level below 70 mg per deciliter. Full Ez-PAVE trial results: nejm.org/doi/full/10.10… Editorial: Paving the Road toward Targeted Lipid Lowering nejm.org/doi/full/10.10… @ACCinTouch

Day 1 at #ACC26. Find us at Booth 1919. Interactive DECIDE demo running all day. Snack-n-Learn Sessions with Dr. Evan Shlofmitz at 1 and 3 p.m. Discover how to plan CT-guided PCI with Heartflow PCI Navigator — turning 3D anatomy, plaque insights, and physiology into confident interventions. #AIinHealthcare #PlaqueAnalysis

Looking forward to sharing our experience with Flyrcado @StFrancis_LI @CHS_LI + @JBourqueMD will share his experience @uvahealthnews @MyASNC #ThinkPET #CVNuc Voices of Change: Flyrcado in Action Sponsored by GE Breakfast panel at 7 AM Courtyard New Orleans Warehouse District

Intravascular Imaging- vs Angiography-Guided Complex PCI: 5-Year Outcomes From a Randomized Trial In patients with complex coronary artery lesions undergoing PCI, intravascular imaging guidance reduced the risk of a composite of cardiac death, target vessel–related myocardial infarction, or clinically driven target vessel revascularization at median follow-up of 5.3 years, compared to angiography guidance #Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare @JACCJournals @ACCinTouch @CMichaelGibson @hvanspall @DrMarthaGulati @Hragy @cardioceptor jacc.org/doi/10.1016/j.…